E-LIB Suche - Ergebnisse für: Aamdal, S.

1

Health-related quality of life in patients with advanced me..:

Aamdal, E. ; Skovlund, E. ; Jacobsen, K.D....
ESMO Open. 7 (2022) 5 - p. 100588 , 2022

Link: https://doi.org/10.1016/..

2

Prognostic biomarkers for immunotherapy with ipilimumab in ..:

Nyakas, M ; Aamdal, E ; Jacobsen, K D...
Clinical and Experimental Immunology. 197 (2019) 1 - p. 74-82 , 2019

Link: https://doi.org/10.1111/..

3

Results from a first in man Phase I/II adjuvant Dendritic C..:

Tryggestad, A.A. ; Bigalke, I. ; Axcrona, K....
Cytotherapy. 19 (2017) 5 - p. S15 , 2017

Link: https://doi.org/10.1016/..

4

Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone..:

Andersson, Y ; Engebraaten, O ; Juell, S...
British Journal of Cancer. 113 (2015) 11 - p. 1548-1555 , 2015

Link: https://doi.org/10.1038/..

5

A first-in-human phase I and pharmacokinetic study of CP-41..:

Venugopal, B. ; Awada, A. ; Evans, T. R. J....
Cancer Chemotherapy and Pharmacology. 76 (2015) 4 - p. 785-792 , 2015

Link: https://doi.org/10.1007/..

6

hTERT/survivin mRNA-loaded dendritic cell vaccination combi..:

Bigalke, I. ; Torhaug, S.B. ; Lundby, M....
Cytotherapy. 16 (2014) 4 - p. S22 , 2014

Link: https://doi.org/10.1016/..

7

Clinical experiences with therapeutic DC vaccines targeting..:

Vik-Mo, E.O. ; Nyakas, M. ; Lote, K....
Cytotherapy. 15 (2013) 4 - p. S14 , 2013

Link: https://doi.org/10.1016/..

8

Health-related quality of life in patients with high-risk m..:

Brandberg, Y. ; Aamdal, S. ; Bastholt, L....
European Journal of Cancer. 48 (2012) 13 - p. 2012-2019 , 2012

Link: https://doi.org/10.1016/..

9

9309 Changes in peripheral blood absolute lymphocyte count ..:

Aamdal, S. ; Wolchock, J.D. ; Weber, J....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 579 , 2009

Link: https://doi.org/10.1016/..

10

9304 Identification of tumor biopsy markers as potential pr..:

Schmidt, H. ; Hamid, O. ; Nissan, A....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 577 , 2009

Link: https://doi.org/10.1016/..

11

725 POSTER A multicenter phase I study of a novel nucleosid..:

Aamdal, S. ; Ahamad, A. ; Evans, J..
European Journal of Cancer Supplements. 5 (2007) 4 - p. 114-115 , 2007

Link: https://doi.org/10.1016/..

12

PCN1 QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS AND TOXICITY (Q..:

Simons, WR ; Aamdal, S ; Hauschild, A..
Value in Health. 10 (2007) 6 - p. A322 , 2007

Link: https://doi.org/10.1016/..

13

104 INVITED Vaccine approaches to kidney cancer in the era ..:

Aamdal, S.
European Journal of Cancer Supplements. 5 (2007) 4 - p. 29 , 2007

Link: https://doi.org/10.1016/..

14

4LB Results of the Nordic randomised adjuvant trial of inte..:

Hansson, J. ; Aamdal, S. ; Bastholt, L....
European Journal of Cancer Supplements. 5 (2007) 6 - p. 4 , 2007

Link: https://doi.org/10.1016/..

15

PD-067 Telomerase peptide vaccination of patients with adva..:

Brunsvig, P. ; Gjertsen, M. ; Kvalheim, G....
Lung Cancer. 49 (2005) - p. S86 , 2005

Link: https://doi.org/10.1016/..